EXPLAINED: 18 - The Real Truth

Unilever will not increase £50bn offer for GSK consumer arm

Company says data shared by GSK suggests ‘fundamental value’ of business no higher than offer

The Guardian - UK · Jan 19, 2022

Unilever won't top $68B bid for GSK consumer healthcare unit

Unilever, the maker of Vaseline skin care products and Dove soap, says it won’t increase a 50 billion-pound ($68.2 billion) offer for GlaxoSmithKline’s consumer healthcare unit that was rejected last week

The Independent UK · Jan 19, 2022

Unilever vows not to increase GSK bid

Unilever has effectively ruled out a fourth takeover approach for GlaxoSmithKline’s consumer healthcare business after vowing not to increase its offer.

Evening Standard · Jan 19, 2022

Unilever’s bid for GSK consumables isn’t quite the shocker it seems

This could be a long campaign and, despite all the difficulties, there is a logic to the proposal

The Guardian - UK · Jan 17, 2022

Unilever punished by City for failed £50bn tilt at GSK

A PROPOSED fire-sale of under-performing food assets failed to stem the blood-letting at Unilever today as the City issued a damning verdict over its failed £50 billion tilt at GlaxoSmithKline.

Evening Standard · Jan 17, 2022

Unilever to expand health and beauty business after failed GSK approach

Dove soap maker’s shares are biggest faller on FTSE 100 after offer for consumer products arm is rebuffed

The Guardian - UK · Jan 17, 2022